Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

A kind of penetrating peptide and its application

A technology for penetrating peptides and amino acids, applied in the fields of peptides, medical preparations containing active ingredients, and drug combinations, can solve the problems of low solubility of doxorubicin, organ toxicity, and low delivery efficiency, and achieve convenient quality control and technology. mature effect

Active Publication Date: 2022-06-10
NANYANG NORMAL UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, doxorubicin still has a series of problems such as low solubility, low delivery efficiency and organ toxicity, so the delivery system and means of doxorubicin need to be improved urgently

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of penetrating peptide and its application
  • A kind of penetrating peptide and its application
  • A kind of penetrating peptide and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 2

[0021] Example 2 Cytotoxicity Experiment

[0022] 1) Take a 48-well plate, add 5×10 4 Cervical cancer Hela cell culture medium, 37 ° C, 5% carbon dioxide incubator for 24 hours until the cells adhere to the wall.

[0023] 2) A medium containing a penetrating peptide at a concentration of 1 mM was prepared, and a medium without a penetrating peptide was used as a negative control well (Control), and cultured at 37° C. with 5% carbon dioxide for 48 hours. The medium formula is: DMEM medium containing 10% fetal bovine serum.

[0024] 3) Add 20 μl MTT to each well of the adherent cells, discard the culture medium after continuing to incubate for 4 hours, add 150 μl DMSO to each well, and shake for 10 minutes.

[0025] 4) Select a wavelength of 490nm, and calculate the cell survival rate by the light absorption value on the microplate reader immunodetector.

[0026] Table 1 Penetrating peptide toxicity test

[0027]

[0028] It can be seen from Table 1 that the membrane-pene...

Embodiment 3

[0029] Example 3 Membrane-penetrating peptide and fluorescence detection experiment

[0030] 1) Add a medium containing a certain concentration of FITC and FITC fluorescently labeled penetrating peptide to the adherent cells, incubate for 30min-4h, then carefully suck off the medium, and wash the adherent cells three times with PBS. The medium formula is: 10% DMEM medium.

[0031] 2) Add trypsin to react for 5 minutes until the cells float, and then add fresh medium to stop the reaction.

[0032] 3) Measure the amount of fluorescence possessed by 10,000 cells in a flow cytometer. FITC was used as control and reference (100%).

[0033] Table 2 Multifunctional peptide-mediated doxorubicin delivery test

[0034]

[0035] It can be seen from Table 2 that the total intracellular fluorescence of the FITC fluorescently labeled membrane-penetrating peptide group was geometrically higher than that of the FITC group, and the membrane-penetrating peptide of the present invention pe...

Embodiment 4

[0036] Example 4 Mediated Penetrating Peptide Delivery Experiment

[0037] 1) Add a medium containing 5 mg / ml doxorubicin and 0.1 mM membrane-penetrating peptide to incubate cervical cancer Hela cells. After incubation for 30 minutes, carefully aspirate the medium, and wash the adherent cells three times with PBS. The medium containing only 5 mg / ml doxorubicin was used as a control. The medium formula is: DMEM medium containing 10% fetal bovine serum.

[0038] 2) Add fresh cell culture medium and culture for 24 hours.

[0039] 3) Add 150 μl DMSO to each well of Hela cells, shake for 10 minutes, and then centrifuge at 10,000 rpm to obtain the supernatant to obtain the intracellular extract.

[0040] 4) The concentration of doxorubicin in the intracellular extract was determined by HPLC. The results were compared with the doxorubicin control group (100%).

[0041] Table 3 Multifunctional Peptide Mediated Doxorubicin Delivery Test

[0042]

[0043] It can be seen from Tab...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a membrane-penetrating peptide, the amino acid sequence of the membrane-penetrating peptide is: Arg-Arg-Lys-Lys-Trp-Trp. The penetrating peptide can mediate the delivery of doxorubicin into cells. The penetrating peptide of the present invention is non-toxic and non-immunogenic. Moreover, the peptide solid-phase synthesis technology is mature, cheap and easy to obtain, and convenient for quality control.

Description

technical field [0001] The invention belongs to the field of biotechnology, and specifically relates to a membrane-penetrating peptide and the application of the membrane-penetrating peptide in mediating delivery of doxorubicin. Background technique [0002] Doxorubicin is a broad-spectrum antitumor antibiotic, which can inhibit the synthesis of tumor cell RNA and DNA, and can kill tumor cells in various growth cycles. Because doxorubicin is highly cost-effective, the global sales of doxorubicin reached US$810 million in 2015. However, doxorubicin still has a series of problems such as low solubility, low delivery efficiency and organ toxicity, so the delivery system and means of doxorubicin need to be improved urgently. [0003] Cell-penetrating peptides (CPPs), referred to as penetrating peptides, are a class of short peptides that can efficiently carry macromolecules into cells, and are widely used in the design of new bionanomaterials. Partial membrane-penetrating pept...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/06A61K47/42A61K31/704A61P35/00
CPCA61K47/42A61P35/00A61K31/704C07K7/06
Inventor 韦宇平惠丰立牛秋红宋玉伟
Owner NANYANG NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com